RU2007103177A - Способ получения в чистом виде кристаллических форм торсемида - Google Patents
Способ получения в чистом виде кристаллических форм торсемида Download PDFInfo
- Publication number
- RU2007103177A RU2007103177A RU2007103177/04A RU2007103177A RU2007103177A RU 2007103177 A RU2007103177 A RU 2007103177A RU 2007103177/04 A RU2007103177/04 A RU 2007103177/04A RU 2007103177 A RU2007103177 A RU 2007103177A RU 2007103177 A RU2007103177 A RU 2007103177A
- Authority
- RU
- Russia
- Prior art keywords
- crystalline form
- torsemide
- crystals
- carried out
- torsemid
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000013078 crystal Substances 0.000 claims 4
- NGBFQHCMQULJNZ-UHFFFAOYSA-N Torsemide Chemical compound CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 NGBFQHCMQULJNZ-UHFFFAOYSA-N 0.000 claims 3
- 229960005461 torasemide Drugs 0.000 claims 3
- 238000000926 separation method Methods 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Claims (5)
1. Способ получения в чистом виде кристаллической формы 1 полиморфного кристаллического торсемида, при котором торсемид растворяют в смеси этанола с водой при нагревании, затем охлаждают и после отделения кристаллов сушат, отличающийся тем, что сушку проводят с одновременной механической нагрузкой на кристаллы, например, в лопастной сушилке, причем кристаллы кристаллической формы 2 переходят в кристаллическую форму 1.
2. Способ по п.1, отличающийся тем, что перед кристаллизацией проводят механическое отделение твердых веществ, в частности, фильтрованием.
3. Способ по п.1 или 2, отличающийся тем, что этанол и воду вводят в массовом соотношении 55:46 (объемном отношении примерно 60:40) с максимальным отклонением каждой доли 15 мас.%.
4. Способ по п.1, отличающийся тем, что для получения чистой кристаллической формы 2 охлаждение проводят с перепадом температур от 0,2 до 1°С/мин, предпочтительно от 0,4°/мин до 0,6°/мин, до температуры ниже 40°С.
5. Способ по п.1, отличающийся тем, что для получения чистой кристаллической формы 2 торсемида непосредственно перед или при достижении температуры насыщения, в частности, при от 70° до 60°С, при охлаждении раствора вводят затравочный кристалл кристаллической формы 2.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA1293/2004 | 2004-07-28 | ||
| AT0129304A AT500576B1 (de) | 2004-07-28 | 2004-07-28 | Verfahren zur reindarstellung von kristallformen von torsemid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2007103177A true RU2007103177A (ru) | 2008-08-10 |
Family
ID=35106999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007103177/04A RU2007103177A (ru) | 2004-07-28 | 2005-07-28 | Способ получения в чистом виде кристаллических форм торсемида |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070260068A1 (ru) |
| EP (1) | EP1773778A1 (ru) |
| JP (1) | JP2008507568A (ru) |
| CN (1) | CN101056856A (ru) |
| AT (1) | AT500576B1 (ru) |
| AU (1) | AU2005266828A1 (ru) |
| CA (1) | CA2575283A1 (ru) |
| MX (1) | MX2007001074A (ru) |
| NO (1) | NO20070856L (ru) |
| RU (1) | RU2007103177A (ru) |
| WO (1) | WO2006010189A1 (ru) |
| ZA (1) | ZA200701438B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102432532B (zh) * | 2011-11-10 | 2014-06-18 | 天津市汉康医药生物技术有限公司 | 高纯度托拉塞米化合物 |
| CN104370805B (zh) * | 2013-08-13 | 2016-09-07 | 天津汉瑞药业有限公司 | 托拉塞米化合物 |
| CN115417810B (zh) * | 2022-09-22 | 2023-10-10 | 南京正科医药股份有限公司 | 一种托拉塞米晶型ⅰ的精制方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3529529A1 (de) * | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
| US6166045A (en) * | 1998-06-02 | 2000-12-26 | Roche Diagnostics Gmbh | Torasemide of modification III |
| HRP20020120A2 (en) * | 1999-08-11 | 2003-10-31 | Teva Pharma | Torsemide polymorphs |
-
2004
- 2004-07-28 AT AT0129304A patent/AT500576B1/de active
-
2005
- 2005-07-28 JP JP2007522871A patent/JP2008507568A/ja active Pending
- 2005-07-28 EP EP05763057A patent/EP1773778A1/de not_active Withdrawn
- 2005-07-28 CN CNA2005800252020A patent/CN101056856A/zh active Pending
- 2005-07-28 WO PCT/AT2005/000299 patent/WO2006010189A1/de not_active Ceased
- 2005-07-28 AU AU2005266828A patent/AU2005266828A1/en not_active Abandoned
- 2005-07-28 CA CA002575283A patent/CA2575283A1/en not_active Abandoned
- 2005-07-28 US US11/658,514 patent/US20070260068A1/en not_active Abandoned
- 2005-07-28 ZA ZA200701438A patent/ZA200701438B/en unknown
- 2005-07-28 RU RU2007103177/04A patent/RU2007103177A/ru not_active Application Discontinuation
- 2005-07-28 MX MX2007001074A patent/MX2007001074A/es not_active Application Discontinuation
-
2007
- 2007-02-14 NO NO20070856A patent/NO20070856L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008507568A (ja) | 2008-03-13 |
| CA2575283A1 (en) | 2006-02-02 |
| AT500576A1 (de) | 2006-02-15 |
| US20070260068A1 (en) | 2007-11-08 |
| AU2005266828A1 (en) | 2006-02-02 |
| AT500576B1 (de) | 2006-11-15 |
| CN101056856A (zh) | 2007-10-17 |
| MX2007001074A (es) | 2007-04-19 |
| WO2006010189A1 (de) | 2006-02-02 |
| NO20070856L (no) | 2006-04-19 |
| ZA200701438B (en) | 2008-06-25 |
| EP1773778A1 (de) | 2007-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014518287A5 (ru) | ||
| RU2007135017A (ru) | Смесь олигосахаридов | |
| JP2003528094A5 (ru) | ||
| RU2004137681A (ru) | Аддукт топирамата и гидрохлорида трамадола и его применения | |
| JP2003528100A5 (ru) | ||
| RU2007103177A (ru) | Способ получения в чистом виде кристаллических форм торсемида | |
| US2588449A (en) | Levulose dihydrate | |
| JPS62158233A (ja) | ビスフエノ−ルＡのｏ，ｐ’−異性体の分離方法 | |
| EP1310504A4 (en) | PROCESS FOR PRODUCING CRYSTALLINE TAGATOSIS | |
| MX2023003704A (es) | Método de purificación de sucralosa. | |
| RU2009135603A (ru) | Способ получения хлористого калия | |
| RU2019104860A (ru) | Способ разделения солей баклофена | |
| KR950000259B1 (ko) | 5'-구아닐산 나트륨의 정석법 | |
| WO2010048786A1 (zh) | 一种红霉素的结晶方法 | |
| FI104738B (fi) | Menetelmä vedettömän fruktoosin kiteyttämiseksi sen vesiliuoksista | |
| KR102884226B1 (ko) | 아족시스트로빈의 정제방법 | |
| RU2797970C1 (ru) | Способ очистки нуклеиновой кислоты | |
| JP7527369B2 (ja) | 核酸の精製方法 | |
| RU2011136706A (ru) | Способ получения шоколадной крошки | |
| RU2017107555A (ru) | Способ получения кристаллического l-аланина | |
| RU2266335C1 (ru) | Способ получения утфеля первой кристаллизации | |
| JPS61178419A (ja) | 重質無水炭酸ナトリウムの製造方法 | |
| CN106478489A (zh) | 一种单硝基邻苯二甲酰亚胺异构体混合物的分离方法 | |
| RU2004116741A (ru) | Способ получения порошка платины | |
| RU2002112400A (ru) | Способ получения бис (1-гидроксиэтан-1,1-дифосфоната(1-)) меди (II) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20090624 |